Tri-Cities Tech Business Update
Pacific Northwest life sciences showcase
The Washington Biotechnology and Biomedical Association and Wilson Sonsini Goodrich & Rosati will hold the first ever Northwest Emerging Company Investor Forum on June 16 in Seattle. This forum will showcase select early-stage, fundable companies based in the Pacific Northwest and will feature SR One Limited, the corporate venture fund of GlaxoSmithKline. SR One is a leading venture capital firm that invests in emerging life science companies that are pursuing innovative science and technologies that will significantly impact medical care. To be considered for participation, submit a one-page executive summary including sector, total equity raised, existing investors, expected date of next financing, 1-2 paragraph summary of technology and opportunity, and executive management team information to Effie Toshav no later than June 1.
